BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9227788)

  • 1. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group.
    Goldenberg DM; Wegener W
    Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
    Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
    Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
    Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
    J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.
    Hughes K; Pinsky CM; Petrelli NJ; Moffat FL; Patt YZ; Hammershaimb L; Goldenberg DM
    Ann Surg; 1997 Nov; 226(5):621-31. PubMed ID: 9389396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer imaging with radiolabeled antibodies.
    Goldenberg DM; Nabi HA
    Semin Nucl Med; 1999 Jan; 29(1):41-8. PubMed ID: 9990682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG).
    Rosner D; Nabi H; Wild L; Ortman-Nabi J; Hreshchyshyn MM
    Cancer Invest; 1995; 13(6):573-82. PubMed ID: 7583706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of 99mTc-anti-carcinoembryonic antigen antibody and 99mTc-sestamibi scintimammography in the evaluation of high risk palpable breast lesions.
    Sanidas EE; Koukouraki S; Velidaki A; Manios A; Stathopoulos E; De Bree E; Kafousi M; Kodogiannis E; Karkavitsas N; Tsiftsis DD
    Nucl Med Commun; 2003 Mar; 24(3):291-6. PubMed ID: 12612470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
    Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
    J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
    Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
    Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
    Lind P; Smola MG; Lechner P; Ratschek M; Klima G; Költringer P; Steindorfer P; Eber O
    Int J Cancer; 1991 Apr; 47(6):865-9. PubMed ID: 2010229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography.
    Buccheri G; Biggi A; Ferrigno D; Leone A; Taviani M; Quaranta M
    Chest; 1993 Sep; 104(3):734-42. PubMed ID: 8365283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
    Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
    J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
    Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
    Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
    Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
    Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer].
    García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM
    Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
    Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
    J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.